Dr. O'Malley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3651 Ridge Mill Dr
Hilliard, OH 43026Phone+1 614-293-3873Fax+1 614-293-3078- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2002 - 2005
- The MetroHealth System/Case Western Reserve UniversityResidency, Obstetrics and Gynecology, 1998 - 2002
- Cleveland Clinic FoundationResidency, Obstetrics and Gynecology, 1998 - 2002
- Wayne State University School of MedicineClass of 1998
- University of Notre DameBA, Pre-Med, 1989 - 1992
Certifications & Licensure
- OH State Medical License 2005 - 2026
- CT State Medical License 2002 - 2006
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma Start of enrollment: 2007 Aug 01
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Join now to see all
Publications & Presentations
PubMed
- 394 citationsBevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Grou...Robert L. Coleman, Mark F. Brady, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong
The Lancet. Oncology. 2017-06-01 - 132 citationsUse and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A. Wright, Angel M. Cronin, Dana Milne, Michael A. Bookman, Robert A. Burger
Journal of Clinical Oncology. 2015-09-10 - 1102 citationsRucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trialRobert L. Coleman, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin
Lancet. 2017-10-28
Journal Articles
- Phase Ib Study of Mirvetuximab Soravtansine, a Folate Receptor Alpha (FRα)-Targeting Antibody-Drug Conjugate (ADC), in Combination with Bevacizumab in Patients with Pl...David M O'Malley, Ursula A Matulonis, Michael J Birrer, Cesar M Castro, Lainie P Martin, Kathleen N Moore, Gynecologic Oncology
Lectures
- Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resi...2019 ASCO Annual Meeting - 6/1/2019
- Mirvetuximab soravtansine, a folate receptor alpha (FR±)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resis...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
- David O'Malley, MD, on Dual Immunotherapy for Advanced Cervical CancerMarch 9th, 2022
- ImmunoGen Announces Mature Data from FORWARD II Expansion Cohort Evaluating Mirvetuximab Soravtansine in Combination with AvastinMay 15th, 2019
- ImmunoGen Announces Positive Findings from the FORWARD II Study of Mirvetuximab Soravtansine Combination Regimens with AvastinMay 16th, 2018
Professional Memberships
- Member
Hospital Affiliations
- The OSUCCC - JamesColumbus, Ohio
- Ohio State University Wexner Medical CenterColumbus, Ohio
- Ohio State University Wexner Medical CenterColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: